The Use of the Terms Negro and Black to Include Persons of Native American Ancestry in Anglo North America

In 1854 the California State Supreme Court sought to bar all non-Caucasians from equal citizenship and civil rights. The court stated: The word Black may include all Negroes, but the term Negro does not include all Black persons . . . . We are of the opinion that the words White, Negro, Mulatto and Black person, whenever they occur in our constitution . . . must be taken in their generic sense . . . that the words Black person, in the 14th section must be taken as contra distinguished from White, and necessarily includes all races other than the Caucasian.[1] As convoluted as the quote may be, it tends to express a strong tendency in the history of the United States, toward creating two broad classes of people: white and non-white, citizen and non-citizen (or semi-citizen)

Fascism: A Review of Its History and Its Present Cultural Reality in the Americas

The Italians may have given us the word “fascismo,” but whether we use that word or the Spanish ”falangismo” or the German “National Socialism” (Naziism) we are talking about a form of social organization which has a complex history. Indeed, many persons wrongly believe that fascism as a political system first achieved state power in Italy in the 1920s. However, fascism in modern times first achieved independent (sovereign) power in the Americas -- in the Argentina of Juan Manuel de Rosas (1830s) and in the Confederate States of America (1860-1865)

Nonlocalized Generation of Correlated Photon Pairs in Degenerate Down-Conversion

The achievement of optimum conversion efficiency in conventional spontaneous parametric down- conversion requires consideration of quantum processes that entail multisite electrodynamic coupling, actively taking place within the conversion material. The physical mechanism, which operates through virtual photon propagation, provides for photon pairs to be emitted from spatially separated sites of photon interaction; occasionally pairs are produced in which each photon emerges from a different point in space. The extent of such nonlocalized generation is influenced by individual variations in both distance and phase correlation. Mathematical analysis of the global contributions from this mechanism provides a quantitative measure for a degree of positional uncertainty in the origin of down-converted emission

Quantum delocalization in photon-pair generation

The generation of correlated photon pairs is a key to the production of entangled quantum states, which have a variety of applications within the area of quantum information. In spontaneous parametric down-conversion—the primary method of generating correlated photon pairs—the associated photon annihilation and creation events are generally thought of as being colocated: The correlated pair of photons is localized with regards to the pump photon and its positional origin. A detailed quantum electrodynamical analysis highlights a mechanism exhibiting the possibility of a delocalized origin for paired output photons: The spatial extent of the region from which the pair is generated can be much larger than previously thought. The theory of both localized and nonlocalized degenerate down-conversion is presented, followed by a quantitative analysis using discrete-volume computational methods. The results may have significant implications for quantum information and imaging applications, and the design of nonlinear optical metamaterials

Interventions to Promote Cancer Awareness and Early Presentation: Systematic Review

Low cancer awareness contributes to delay in presentation for cancer symptoms and may lead to delay in cancer diagnosis. The aim of this study was to review the evidence for the effectiveness of interventions to raise cancer awareness and promote early presentation in cancer to inform policy and future research. We searched bibliographic databases and reference lists for randomised controlled trials of interventions delivered to individuals, and controlled or uncontrolled studies of interventions delivered to communities. We found some evidence that interventions delivered to individuals modestly increase cancer awareness in the short term and insufficient evidence that they promote early presentation. We found limited evidence that public education campaigns reduce stage at presentation of breast cancer, malignant melanoma and retinoblastoma

Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial

Background Third-generation aromatase inhibitors are more effective than tamoxifen for preventing recurrence in postmenopausal women with hormone-receptor-positive invasive breast cancer. However, it is not known whether anastrozole is more effective than tamoxifen for women with hormone-receptor-positive ductal carcinoma in situ (DCIS). Here, we compare the efficacy of anastrozole with that of tamoxifen in postmenopausal women with hormone-receptor-positive DCIS. Methods In a double-blind, multicentre, randomised placebo-controlled trial, we recruited women who had been diagnosed with locally excised, hormone-receptor-positive DCIS. Eligible women were randomly assigned in a 1:1 ratio by central computer allocation to receive 1 mg oral anastrozole or 20 mg oral tamoxifen every day for 5 years. Randomisation was stratified by major centre or hub and was done in blocks (six, eight, or ten). All trial personnel, participants, and clinicians were masked to treatment allocation and only the trial statistician had access to treatment allocation. The primary endpoint was all recurrence, including recurrent DCIS and new contralateral tumours. All analyses were done on a modified intention-to-treat basis (in all women who were randomised and did not revoke consent for their data to be included) and proportional hazard models were used to compute hazard ratios and corresponding confidence intervals. This trial is registered at the ISRCTN registry, number ISRCTN37546358. Results Between March 3, 2003, and Feb 8, 2012, we enrolled 2980 postmenopausal women from 236 centres in 14 countries and randomly assigned them to receive anastrozole (1449 analysed) or tamoxifen (1489 analysed). Median follow-up was 7·2 years (IQR 5·6–8·9), and 144 breast cancer recurrences were recorded. We noted no statistically significant difference in overall recurrence (67 recurrences for anastrozole vs 77 for tamoxifen; HR 0·89 [95% CI 0·64–1·23]). The non-inferiority of anastrozole was established (upper 95% CI <1·25), but its superiority to tamoxifen was not (p=0·49). A total of 69 deaths were recorded (33 for anastrozole vs 36 for tamoxifen; HR 0·93 [95% CI 0·58–1·50], p=0·78), and no specific cause was more common in one group than the other. The number of women reporting any adverse event was similar between anastrozole (1323 women, 91%) and tamoxifen (1379 women, 93%); the side-effect profiles of the two drugs differed, with more fractures, musculoskeletal events, hypercholesterolaemia, and strokes with anastrozole and more muscle spasm, gynaecological cancers and symptoms, vasomotor symptoms, and deep vein thromboses with tamoxifen. Conclusions No clear efficacy differences were seen between the two treatments. Anastrozole offers another treatment option for postmenopausal women with hormone-receptor-positive DCIS, which may be be more appropriate for some women with contraindications for tamoxifen. Longer follow-up will be necessary to fully evaluate treatment differences

Somatic mutations affect key pathways in lung adenocarcinoma

Determining the genetic basis of cancer requires comprehensive analyses of large collections of histopathologically well- classified primary tumours. Here we report the results of a collaborative study to discover somatic mutations in 188 human lung adenocarcinomas. DNA sequencing of 623 genes with known or potential relationships to cancer revealed more than 1,000 somatic mutations across the samples. Our analysis identified 26 genes that are mutated at significantly high frequencies and thus are probably involved in carcinogenesis. The frequently mutated genes include tyrosine kinases, among them the EGFR homologue ERBB4; multiple ephrin receptor genes, notably EPHA3; vascular endothelial growth factor receptor KDR; and NTRK genes. These data provide evidence of somatic mutations in primary lung adenocarcinoma for several tumour suppressor genes involved in other cancers - including NF1, APC, RB1 and ATM - and for sequence changes in PTPRD as well as the frequently deleted gene LRP1B. The observed mutational profiles correlate with clinical features, smoking status and DNA repair defects. These results are reinforced by data integration including single nucleotide polymorphism array and gene expression array. Our findings shed further light on several important signalling pathways involved in lung adenocarcinoma, and suggest new molecular targets for treatment.National Human Genome Research InstituteWe thank A. Lash, M.F. Zakowski, M.G. Kris and V. Rusch for intellectual contributions, and many members of the Baylor Human Genome Sequencing Center, the Broad Institute of Harvard and MIT, and the Genome Center at Washington University for support. This work was funded by grants from the National Human Genome Research Institute to E.S.L., R.A.G. and R.K.W.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/62885/1/nature07423.pd